News

Treatment slows moderate to severe Alzheimer's disease

BMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7393.784 (Published 12 April 2003) Cite this as: BMJ 2003;326:784
  1. Janice Hopkins Tanne
  1. New York

    For the first time, a treatment has been shown to slow the mental and physical decline of patients with moderate to severe Alzheimer's disease by about six months (New England Journal of Medicine 2003;348:1333-41).

    The US researchers conducted a double blind, randomised controlled trial of memantine. The drug had been marketed in Germany by Merz Pharmaceuticals for a decade for Parkinson's disease and other neurodegenerative diseases before being licensed in May 2002 by the European Union …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe